Osteopenia of prematurity has become a common problem recently because of improved survival rates of infants with very low birth weight (VLBW). The incidence of neonatal osteopenia is inversely correlated with gestational age and birth weight. Herein, we present four cases of preterm osteopenia that were referred to the pediatric endocrinology outpatient clinic with diverse clinical and laborat...

Enamel formation (amelogenesis) in the human dentition begins in utero. The process has been investigated widely in the primary dentition in animals, and to a much lesser extent in humans. Studies have confirmed that amelogenesis occurs in distinct stages. 1 Each of these stages may be affected by extreme systemic physiological changes with hypoplasia, hypomineralization, or opacities of enamel...

AIM In this study, we aimed to investigate the utility of tubular reabsorption of phosphorus in the diagnosis of osteopenia of prematurity in addition to biochemical markers. MATERIALS AND METHOD Premature babies with a gestational age of ≤32 weeks and/or a birth weight of ≤1 500 g who were hospitalized in the neonatal intensive care unit between June 2009 and March 2011 were included in the ...

Metabolic bone disease of prematurity is a condition characterized by reduction in bone mineral content (osteopenia). It is a problem faced by very low birth weight (VLBW) infants because of lack of fetal mineralization during the last trimester. Our aim was to assess serum alkaline phosphatase (ALP) level as an early biomarker for osteopenia in premature infants and to estimate an optimal cuto...

Introduction: Preterm infants, with a gestational age <29 weeks are at high risk to suffer from osteopenia of prematurity (39%) and may develop spontaneous fractures in 2%-10%. In addition to an insufficient prenatal bone mineralization, the inadequate supplementation with calcium/phosphorus and vitamin D3, immobility, prolonged parenteral nutrition and adverse effects of steroids or diuretics ...

purpose: to study the effects of adding intravitreal bevacizumab (avastin) to conventional laser treatment on regression of retinal neovascularization in threshold rop. methods: intravitreal injection of bevacizumab (1.25 mg) in one eye of each of three newborns with threshold rop was performed in addition to laser treatment. the other eye of each patient was treated with laser alone. changes i...